A Study to Evaluate Immunogenicity of Intramuscular Full-Dose and Intradermal Fractional Dose of IPV

NCT03239496 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

773

Enrollment

OTHER

Sponsor class

Conditions

Poliomyelitis

Interventions

BIOLOGICAL: IPV
BIOLOGICAL: f-IPV

Sponsor

Fidec Corporation

Collaborators

[object Object]